XGEN Venture Closes €180M Life Sciences Fund in Italy

Team S · 2024-12-20T09:53:41.000Z

XGEN Venture, an Italy-based venture capital firm, has successfully closed its XGEN Venture Life Sciences Fund at approximately €180 million (US$187 million), surpassing initial expectations. The fund aims to support early-stage investments in biotechnology, medical devices, and diagnostics sectors. Team: 1. Paolo Fundarò: Co-founder and Managing Partner 2. Federica Draghi: Co-founder and Managing Partner, oversees ESG strategy 3. Daniele Scarinci: Co-founder and Managing Partner Investors: XGEN Venture has already invested in six startups and plans to make approximately nine more investments over the next two to three years. The firm employs a strategic approach, leveraging its network of scientific experts, entrepreneurs, and industry leaders to accelerate growth and innovation within its portfolio companies The fund's success highlights the growing interest in life sciences innovation and the potential for both societal benefits and strong financial returns in this sector. XGEN Venture aims to establish itself as a leading player in the European venture capital market, focusing on early-stage life sciences investments

Member Login Get Access

XGEN Venture Closes €180M Life Sciences Fund in Italy | Newnex